ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,421Medicare Part D Prescriptions Filled, Including Refills
$616K Total Retail Price of All Prescriptions
451 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 329 302
AMLODIPINE BESYLATE 326 315
LISINOPRIL 283 241
OMEPRAZOLE 252 228
METOPROLOL SUCCINATE 228 217
METOPROLOL TARTRATE 218 206
LOSARTAN POTASSIUM 215 206
SIMVASTATIN 205 194
FUROSEMIDE 204 191
DONEPEZIL HCL 201 195
ATORVASTATIN CALCIUM 196 188
PRAVASTATIN SODIUM 180 146
TRAMADOL HCL 172 160
NAMENDA 160 160
METFORMIN HCL 158 129
CARVEDILOL 129 111
HYDROCHLOROTHIAZIDE 126 118
CRESTOR 123 123
CITALOPRAM HBR 116 101
CYMBALTA 112 92
SERTRALINE HCL 102 89
ATENOLOL 99 99
MIRTAZAPINE 81 77
ZOLPIDEM TARTRATE 79 60
CELEBREX 74 73
CLOPIDOGREL 73 58
WARFARIN SODIUM 70 69
GLIMEPIRIDE 69 61
ENALAPRIL MALEATE 65 62
LOSARTAN-HYDROCHLOROTHIAZIDE 64 63
PANTOPRAZOLE SODIUM 64 59
HYDROCODONE-ACETAMINOPHEN 62 62 S3
LIDODERM 62 61
ALLOPURINOL 61 53
PLAVIX 60 54
ESCITALOPRAM OXALATE 58 58
PREDNISONE 56 56
DIGOXIN 55 55
POTASSIUM CHLORIDE 54 54
SYNTHROID 53 53
DIOVAN 51 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.